Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-06-08T08:45:55.398Z Has data issue: false hasContentIssue false
  • English
  • Français

Controversies in Clinical Research Ethics

Published online by Cambridge University Press:  01 January 2021

Robert M. Sade
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposium Articles: Introduction
Information
Journal of Law, Medicine & Ethics , Volume 45 , Issue 3: Symposium - Controversies in Clinical Research Ethics , Fall 2017 , pp. 291 - 294
Copyright
Copyright © American Society of Law, Medicine and Ethics 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Grey, D. J. R., “‘To Bring This Useful Invention into Fashion in England’: Mary Wortley Montagu as Medical Expert,” in Barnard, T., ed., British Women in the Intellectual World in the Long 18th Century (New York: Routledge. 2016): at 15-32.Google Scholar
Hopkins, D. R., The Greatest Killer: Smallpox in History (Chicago: University of Chicago Press. 2002): at 80.CrossRefGoogle Scholar
Schwartz, R., “Drawing the Line at Age 14: Why Adolescents Should Be Able to Consent to Participation in Research,” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 295–306CrossRefGoogle Scholar
Cherry, M. J., “Adolescents Lack Sufficient Maturity to Consent to Medical Research,” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 307-317.CrossRefGoogle Scholar
Shuster, E., “Fifty Years Later: The Significance of the Nuremberg Code,” New England Journal of Medicine 337 (1997): 1436-1440.Google Scholar
Rhodes, R., “When Is Participation in Research a Moral Duty?” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 318-326.CrossRefGoogle Scholar
Yarborough, M., “Why There Is No Obligation to Participate in Clinical Research,” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 327-332.Google Scholar
Wolf, S. M., “The Continuing Evolution of Ethical Standards for Genomic Sequencing in Clinical Care: Restoring Patient Choice,” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 333-340.Google Scholar
Schnipper, L. E., “Central IRB Review Is an Essential Requirement for Cancer Clinical Trials,” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 341-347.CrossRefGoogle Scholar
Moon, M. R., “Can Central IRBs Replace Local Review?” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 348-351.CrossRefGoogle Scholar
Shepherd, L., “Informed Consent for Comparative Effectiveness Research Should Include Risks of Standard Care,” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 351-364.CrossRefGoogle Scholar
Lantos, J. D., “Informed Consent for Comparative Effectiveness Research Should Not Consider the Risks of the Standard Therapies That Are Being Studied as Risks of the Research,” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 365-374.Google Scholar
Ellenberg, S. S. and Joffe, S., “Studying Effects of Medical Treatments: Randomized Clinical Trials and the Alternatives,” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 375-381.CrossRefGoogle Scholar
Schüklenk, U. and Smalling, R., “The Moral Case for Granting Catastrophically Ill Patients the Right to Access Unregistered Medical Interventions,” Journal of Law, Medicine & Ethics 45, no. 3 (2017): 382-391.Google Scholar